A company’s plan to edit the genomes of human embryos worries some researchers — but it might reflect the changing attitudes ...

Innovation is never easy. It requires the audacity to create a new path, one where we will encounter novel obstacles that demand both resourcefulness and bold imagination. But when we stand together, ...

A new study has revealed that the gene HMGN1 is a key driver of congenital heart defects (CHDs) in Down syndrome. Using ...

In a significant leap forward for neuroscience, researchers at the University of California, Santa Barbara, have successfully ...

The latest trading day saw CRISPR Therapeutics AG (CRSP) settling at $62.56, representing a -2.51% change from its previous close.

More about Caribou Biosciences Caribou Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on CRISPR genome-editing technology. The company specializes in developing allogeneic CAR ...

A lthough still in its early days, CRISPR has already been called the most powerful scientific tool of the century. Using ...

ICHORtec GmbH is pleased to announce an expanded research collaboration with the laboratory of Professor Gregory A. Newby in the Department of Genetic Medicine at the Johns Hopkins University School ...

Over the past two decades, synthetic biology has fueled advancements across a broad range of disciplines, including agriculture, bioremediation, biofuel production, and chemical manufacturing. Today, ...

Explore how oligonucleotides are reshaping therapeutics, diagnostics and CRISPR with rapid, scalable and personalized ...

A researcher at the University of Houston finds management of diabetic ketoacidosis may center around reducing ketone levels ...

Chocolate prices have been rising due to complications in the supply chain, but Penn State researchers have made a ...